The historical rank and industry rank for Pressure BioSciences's Net Margin % or its related term are showing as below:
PBIO'
s Net Margin % Range Over the Past 10 Years
Min: -1925.03 Med: -561.32 Max: -136.99
Current: -1925.03
PBIO's Net Margin % is ranked worse than 94.76% of 821
companies
in the Medical Devices & Instruments industry
Industry Median: -1.28
vs PBIO: -1925.03
Pressure BioSciences Net Margin % Historical Data
The historical data trend for Pressure BioSciences's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pressure BioSciences's Net Margin %
For the Medical Devices subindustry, Pressure BioSciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pressure BioSciences's Net Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pressure BioSciences's Net Margin % distribution charts can be found below:
* The bar in red indicates where Pressure BioSciences's Net Margin % falls into.
Pressure BioSciences Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Pressure BioSciences's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pressure BioSciences (OTCPK:PBIO) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Pressure BioSciences Net Margin % Related Terms
Thank you for viewing the detailed overview of Pressure BioSciences's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of enabling, pressure-based platform solutions for the world-wide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PBIO has been successfully added to your 